By C. Ryan Barber | February 27, 2019
Cohen's corporate engagements created controversy for his clients and were cited by critics as examples of shadow lobbying.
By Jenna Greene | February 26, 2019
If cross-examination is an art form, then Wilkinson Walsh + Eskovitz name partners Alexandra Walsh and Sean Eskovitz are masters, leading a trial team defending Bayer AG against a $600 million class action over its One A Day multivitamin.
By Max Mitchell | February 22, 2019
McKesson, which is facing claims that it misrepresented the vaccine's safety, filed a motion to dismiss Thursday in the U.S. District Court for the Eastern District of Pennsylvania, contending that 92 cases should be dismissed because the complaints failed to give sufficient details about the allegations.
By Jenna Greene | February 14, 2019
A fed-up magistrate judge in Delaware ordered pharma giant AbbVie to turn over requested discovery materials to Boehringer Ingelheim in a patent fight over Humira, the world's best-selling drug.
By Jenna Greene | February 8, 2019
Latham & Watkins global IP co-chair Michael Morin and partner David Frazier delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.
By Amanda Bronstad | February 6, 2019
U.S. District Judge Dan Polster heard testimony Wednesday from Baker Hostetler partner Carole Rendon about her former job as U.S. Attorney for the Northern District of Ohio, during which she headed an opioid task force.
By Jenna Greene | February 6, 2019
It's not uncommon for winners and losers to spin the results of a jury verdict, but rarely will two sides offer flatly contradictory takes on what went down.
By Jenna Greene | February 1, 2019
Express Scripts faced a $120 million breach of contract claim by compounding pharmacy HM. Lyle and co-counsel from Husch Blackwell not only defeated the suit, they won a $20 million counter-claim.
By Scott Graham | January 28, 2019
MorphoSys and Kirkland & Ellis had accused a Janssen Pharmaceuticals biologic of infringing, but Judge Leonard Stark ruled MorphoSys' patents invalid for lack of enablement.
By Amanda Bronstad | January 28, 2019
Plaintiffs, appealing three defense verdicts, responded on Friday to a cross-appeal that sought to toss 20,000 cases over Xarelto on federal pre-emption.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS